More on LQDA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+2,300.0% Growth)
- Ratings (6.9 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Liquidia Technologies (NQ:LQDA)
Delayed: 68.66 +0.03 (0.04%)
Prev. Close $68.63  
Open$67.91 
52 Wk High$ 
52 Wk Low$ 
Day High$69.47 
Day Low$67.40 
P/E N/A  
EPS$ 
Volume902,254 

Friends, Peers and Foes (?): SANM, CAMT, INTA, SNDX, ADBE (more...)

Sep 3, 2026 07:30 AM FDA grants fast track status to Liquidia's Yutrepia for rare condition
Sep 3, 2026 07:30 AM FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
Sep 2, 2026 08:30 AM Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress
Sep 1, 2026 08:30 AM Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference
Aug 25, 2026 04:31 PM Form 4 Liquidia Corp For: Aug 21 Filed by: Adair Jason
Aug 21, 2026 04:37 PM Form 144 Liquidia Corp Filed by: Adair Jason
Aug 21, 2026 04:30 PM Form 4 Liquidia Corp For: Aug 19 Filed by: Rielly-Gauvin Katherine
Aug 19, 2026 06:21 PM Form 4 Liquidia Corp For: Aug 17 Filed by: Saggar Rajeev
Aug 19, 2026 04:26 PM Form 144 Liquidia Corp Filed by: Rielly-Gauvin Katherine
Aug 19, 2026 04:04 PM Form 144 Liquidia Corp Filed by: Saggar Rajeev
View All Articles

Entities mentioned with LQDA

View All Entities